PALO ALTO, Calif., July 26, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that the University HospitalsLeuven (UZ Leuven) in Belgium, have ordered the new Halcyon™ treatment system. Scheduled to be installed in September 2017, the new system provides the opportunity for UZ Leuven
The Halcyon™ system is engineered to revolutionize clinical workflow by simplifying and enhancing virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). With its streamlined workflow, Halcyon only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies nearing end of life. Halcyon is well suited to handle the majority of cancer patients, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.
"We are excited about the opportunity to add the Halcyon system to our radiation oncology department," said professor Karin Haustermans, MD, chair of the department, UZ Leuven. "The system will be easier to operate for our therapists, and its human-centered design allows for a much closer connection between the patient and therapist."
"The goal with Halcyon was to design a treatment system that expands the availability of high quality cancer care globally and help save the lives of millions more cancer patients," said Kolleen Kennedy, president of Varian's Oncology Systems business. "We are pleased UZ Leuven is one of the first centers to order this new system, and that they will be able to take advantage of its many features to continue to deliver high quality care to their patients."
For more information on Halcyon visit www.varian.com/halcyon.
About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact Mark PlungyVarian Medical Systems+1 (650) 424-5630 email@example.com
View original content:http://www.prnewswire.com/news-releases/uz-leuven-orders-varian-halcyon-cancer-treatment-system-300494074.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All